BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19245939)

  • 21. Innate host defenses against Cryptococcus neoformans.
    Hole C; Wormley FL
    J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of Laccase Expression to Immune Response against Cryptococcus gattii Infection.
    Hansakon A; Ngamskulrungroj P; Angkasekwinai P
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptococcus.
    McDonald T; Wiesner DL; Nielsen K
    Curr Biol; 2012 Jul; 22(14):R554-5. PubMed ID: 22835785
    [No Abstract]   [Full Text] [Related]  

  • 24. Maintenance of Mitochondrial Morphology in Cryptococcus neoformans Is Critical for Stress Resistance and Virulence.
    Chang AL; Doering TL
    mBio; 2018 Nov; 9(6):. PubMed ID: 30401774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of optimal host strain for molecular pathogenesis studies on Cryptococcus gattii.
    Chaturvedi S; Ren P; Narasipura SD; Chaturvedi V
    Mycopathologia; 2005 Oct; 160(3):207-15. PubMed ID: 16205969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance and Tolerance to Cryptococcal Infection: An Intricate Balance That Controls the Development of Disease.
    Shourian M; Qureshi ST
    Front Immunol; 2019; 10():66. PubMed ID: 30761136
    [No Abstract]   [Full Text] [Related]  

  • 27. Basic principles of the virulence of
    Zaragoza O
    Virulence; 2019 Dec; 10(1):490-501. PubMed ID: 31119976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What makes Cryptococcus gattii a pathogen?
    Bielska E; May RC
    FEMS Yeast Res; 2016 Feb; 16(1):fov106. PubMed ID: 26614308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hybrids and hybridization in the Cryptococcus neoformans and Cryptococcus gattii species complexes.
    Samarasinghe H; Xu J
    Infect Genet Evol; 2018 Dec; 66():245-255. PubMed ID: 30342094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment strategies for cryptococcal infection: challenges, advances and future outlook.
    Iyer KR; Revie NM; Fu C; Robbins N; Cowen LE
    Nat Rev Microbiol; 2021 Jul; 19(7):454-466. PubMed ID: 33558691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
    Damasceno-Escoura AH; de Souza ML; de Oliveira Nunes F; Pardi TC; Gazotto FC; Florentino DH; Mora DJ; Silva-Vergara ML
    Mycopathologia; 2019 Feb; 184(1):65-71. PubMed ID: 30415450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
    Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
    Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phylogeny and phenotypic characterization of pathogenic Cryptococcus species and closely related saprobic taxa in the Tremellales.
    Findley K; Rodriguez-Carres M; Metin B; Kroiss J; Fonseca A; Vilgalys R; Heitman J
    Eukaryot Cell; 2009 Mar; 8(3):353-61. PubMed ID: 19151324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of proton nuclear magnetic resonance spectroscopy to the study of Cryptococcus and cryptococcosis.
    Sorrell TC; Wright LC; Malik R; Himmelreich U
    FEMS Yeast Res; 2006 Jun; 6(4):558-66. PubMed ID: 16696651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptococcus: the once-sleeping giant is fully awake.
    Levitz SM; Boekhout T
    FEMS Yeast Res; 2006 Jun; 6(4):461-2. PubMed ID: 16696641
    [No Abstract]   [Full Text] [Related]  

  • 36. Rising to the challenge of multiple Cryptococcus species and the diseases they cause.
    Idnurm A; Lin X
    Fungal Genet Biol; 2015 May; 78():1-6. PubMed ID: 25983191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii.
    Ngamskulrungroj P; Himmelreich U; Breger JA; Wilson C; Chayakulkeeree M; Krockenberger MB; Malik R; Daniel HM; Toffaletti D; Djordjevic JT; Mylonakis E; Meyer W; Perfect JR
    Infect Immun; 2009 Oct; 77(10):4584-96. PubMed ID: 19651856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Know your enemy: how to build and vanquish a global fungal scourge.
    Wang X; Li W; Sun S; Kozubowski L; Lee SC; Feretzaki M; Heitman J
    Mycopathologia; 2012 Jun; 173(5-6):295-301. PubMed ID: 21997858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammalian model hosts of cryptococcal infection.
    Carroll SF; Guillot L; Qureshi ST
    Comp Med; 2007 Feb; 57(1):9-17. PubMed ID: 17348287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of Cryptococcus Meningoencephalitis].
    Miyazato A
    Med Mycol J; 2016; 57(1):J27-32. PubMed ID: 26936349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.